• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Develop your practice as a clinical trials site

Article

A series of courses aim to help clinicians and eye researchers keep up with state-of-the-art approaches to the design, construction, and execution of clinical trials.

Key Points

One such course will take place prior to the start of the annual meeting of the American Academy of Ophthalmology (AAO) in Orlando in October. This CME-accredited course is free to AAO registrants.

Details are as follows:

Friday, Oct. 21

4 to 9 p.m. with dinner

Orlando

Mae Gordon, PhD, professor, Department of Ophthalmology and Visual Sciences and the Division of Biostatistics at Washington University School of Medicine, St. Louis, and other renowned faculty will provide guidelines and information necessary to develop your practice as a clinical trial site.

Space is limited and is on a first-come, first-served basis. Go to http://www.arvo.org/ctes/ for additional information.

$40,000 grants in eye research

The ARVO AFER is accepting applications for two new research grants made available through the support of Genentech and Vistakon:

Related Videos
 John Bladen, MBBS, BSc, MRCS, PGCert, PhD, FRCOphth, consultant ophthalmologist and oculoplastic surgeon, King's College Hospital NHS Foundation Trust, London, UK, speaks with Ophthalmology Times Europe's® Caroline Richards
rande, CFP, and John S. Grande, CFP, of Grande Financial Services, continue their discussion with Ophthalmology Times®' Sheryl Stevenson
What keeps you up at night?
S.K. Steven Houston III, MD, discusses retina innovations in use in his practice, including the NGENUITY 1.4 upgrade from Alcon
Caesar Luo, MD, shares his key take-aways on diabetic retinopathy progression in anti-VEGF versus FA implant
© 2024 MJH Life Sciences

All rights reserved.